Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News electroCore, Inc. ECOR

Healthcare Medical Devices
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS... see more

Recent & Breaking News (NDAQ:ECOR)

electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

GlobeNewswire June 6, 2024

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

GlobeNewswire June 3, 2024

Firefly Neuroscience, an AI-Driven Brain Health Company, Names Brian S. Posner to its Board of Directors, Upon Closing of Its Merger Transaction with WaveDancer

GlobeNewswire May 29, 2024

electroCore Announces First Quarter 2024 Financial Results

GlobeNewswire May 8, 2024

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire May 3, 2024

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

GlobeNewswire May 1, 2024

Truvaga(TM) Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion

GlobeNewswire April 30, 2024

electroCore Announces the Launch of Truvaga Plus® for General Wellness

GlobeNewswire April 8, 2024

electroCore Expands Intellectual Property Portfolio

GlobeNewswire April 2, 2024

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 13, 2024

electroCore to Participate in Upcoming Investor Conferences

GlobeNewswire March 12, 2024

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024

GlobeNewswire March 5, 2024

electroCore Expands Intellectual Property Portfolio

GlobeNewswire February 6, 2024

electroCore Expands Intellectual Property Portfolio

GlobeNewswire January 9, 2024

electroCore Expands Intellectual Property Portfolio

GlobeNewswire December 26, 2023

electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology

GlobeNewswire December 12, 2023

Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore(TM) Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023

GlobeNewswire November 15, 2023

electroCore Announces Third Quarter 2023 Financial Results

GlobeNewswire November 8, 2023

electroCore to Participate in Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum

GlobeNewswire November 7, 2023

Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting

GlobeNewswire October 24, 2023